BI 836826
Showing 1 - 25 of 1,398
Chronic Lymphocytic Leukemia (CLL) Trial in Columbus, Salt Lake City (Idelalisib, BI 836826)
Terminated
- Chronic Lymphocytic Leukemia (CLL)
- Idelalisib
- BI 836826
-
Columbus, Ohio
- +1 more
Nov 23, 2020
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Duarte, Boston, Portland (BI 836826, Ibrutinib)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- BI 836826
- Ibrutinib
-
Duarte, California
- +2 more
Sep 8, 2020
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Belgium, France, Germany (BI 836826)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- BI 836826
-
Bruxelles, Belgium
- +9 more
Aug 10, 2020
Lymphoma, Non-Hodgkin Trial in France, Germany, Korea, Republic of (BI 836826)
Completed
- Lymphoma, Non-Hodgkin
- BI 836826
-
Marseille Cedex 09, France
- +11 more
Aug 10, 2020
Lymphoma, Large B-Cell, Diffuse Trial in Belgium, Italy, Spain (BI 836826, GemOx, Rituximab)
Completed
- Lymphoma, Large B-Cell, Diffuse
- BI 836826
- +2 more
-
Hasselt, Belgium
- +6 more
Mar 13, 2019
Adolescent Cancer, Young Adult Cancer, Body Image Trial in Ann Arbor (BI Focused writing, Control)
Not yet recruiting
- Adolescent Cancer
- +2 more
- BI Focused writing
- Control
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Sep 13, 2023
Leukemia, Lymphocytic, Chronic, B-Cell Trial (Venetoclax, BI 836826)
Withdrawn
- Leukemia, Lymphocytic, Chronic, B-Cell
- Venetoclax
- BI 836826
- (no location specified)
Jan 8, 2018
Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma, NSCLC (NSCLC) Trial in Amsterdam (BI 765063, Ezabenlimab, [89Zr]Zr-
Recruiting
- Carcinoma, Squamous Cell of Head and Neck (HNSCC)
- +2 more
- BI 765063
- +4 more
-
Amsterdam, NetherlandsAmsterdam UMC Locatie VUMC
Jan 9, 2023
Healthy Trial (BI 1015550)
Not yet recruiting
- Healthy
- BI 1015550
- (no location specified)
Nov 15, 2023
Tumors Trial in Spain, United Kingdom, United States (BI 1387446, BI 754091)
Active, not recruiting
- Neoplasms
- BI 1387446
- BI 754091
-
Chapel Hill, North Carolina
- +7 more
Jan 23, 2023
Myocardial Infarction Trial (BI 765845, Placebo matching BI 765845)
Not yet recruiting
- Myocardial Infarction
- BI 765845
- Placebo matching BI 765845
- (no location specified)
Nov 15, 2023
Hernia, Inguinal Trial (Erector spinae plane block)
Not yet recruiting
- Hernia, Inguinal
- Erector spinae plane block
- (no location specified)
Nov 30, 2023
Solid Tumor, KRAS Mutation Trial (BI 3706674)
Not yet recruiting
- Solid Tumor, KRAS Mutation
- BI 3706674
- (no location specified)
Sep 29, 2023
Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)
Not yet recruiting
- Healthy
- BI 1810631 (C-14) formulation 1
- +2 more
- (no location specified)
May 25, 2023
Bronchiectasis Trial (BI 1291583, Placebo matching BI 1291583)
Not yet recruiting
- Bronchiectasis
- BI 1291583
- Placebo matching BI 1291583
- (no location specified)
Apr 26, 2023
Healthy Trial (BI 1015550, BI 1015550 mixed with [C-14]-BI 1015550)
Not yet recruiting
- Healthy
- BI 1015550
- BI 1015550 mixed with [C-14]-BI 1015550
- (no location specified)
Feb 6, 2023
Non-alcoholic Fatty Liver Disease, Obesity Trial (BI 3006337, Placebo matching BI 3006337)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease
- Obesity
- BI 3006337
- Placebo matching BI 3006337
- (no location specified)
Jul 25, 2023
Solid Tumors Trial in Budapest ([¹4C]-BI 907828 mixed with BI 907828 (formulation 1), [¹4C]-BI 907828 mixed with BI 907828
Recruiting
- Solid Tumors
- [¹⁴C]-BI 907828 mixed with BI 907828 (formulation 1)
- +2 more
-
Budapest, HungaryPRA Hungary Ltd.
Jan 9, 2023
Geographic Atrophy Trial (BI 771716)
Not yet recruiting
- Geographic Atrophy
- BI 771716
- (no location specified)
Aug 29, 2023
Healthy Trial (BI 3000202, Placebo matching BI 3000202)
Not yet recruiting
- Healthy
- BI 3000202
- Placebo matching BI 3000202
- (no location specified)
Jul 7, 2023
Solid Tumors Trial (BI 1821736)
Not yet recruiting
- Solid Tumors
- BI 1821736
- (no location specified)
Apr 21, 2023
Healthy Trial (BI 1839100, Placebo matching BI 1839100)
Not yet recruiting
- Healthy
- BI 1839100
- Placebo matching BI 1839100
- (no location specified)
Feb 13, 2023
Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)
Not yet recruiting
- Small Cell Lung Carcinoma
- Neuroendocrine Neoplasms
- BI 764532
- (no location specified)
May 22, 2023
Tumors Trial in Belgium, Japan, United States (BI 907828, BI 754091, BI 754111)
Recruiting
- Neoplasms
- BI 907828
- +2 more
-
Santa Monica, California
- +16 more
Jan 23, 2023